Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells
2011 ◽
Vol 29
(4)
◽
pp. 247-252
◽
2016 ◽
2016 ◽
2016 ◽
2016 ◽
2016 ◽
Vol 36
(11)
◽
pp. 5731-5742
◽